Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MetrovacesaXMAD:MVC -1.80%76 Days Sales Outstanding is 43.76 as of Jun. 2026, which is 33% above its 10-year median of 32.97. GuruFocus rates XMAD:MVC with a GF Score™ of 76/100 and a GF Value™ of €13.62 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,661 Real Estate companies, Metrovacesa ranks better than 54.43% on this metric.
Metrovacesa's average Accounts Receivable for the
six
months ended in Jun. 2026 was €75.7 Mil. Metrovacesa's Revenue for the
six
months ended in Jun. 2026 was €315.8 Mil.
Hence, Metrovacesa's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 43.76.
The historical rank and industry rank for Metrovacesa's Days Sales Outstanding or its related term are showing as below:
XMAD:MVC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.17 Med: 32.97 Max: 277.46
Current: 29.24
During the past 13 years, Metrovacesa's highest Days Sales Outstanding was 277.46. The lowest was 3.17. And the median was 32.97.
XMAD:MVC's Days Sales Outstanding is ranked better than 54.43% of 1661
companies
in the Real Estate industry
Industry Median: 34.57
vs XMAD:MVC: 29.24
Metrovacesa's Days Sales Outstanding
declined
from Jun. 2025 (86.14) to Jun. 2026 (43.76).
Metrovacesa (XMAD:MVC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Metrovacesa Days Sales Outstanding Related Terms
Metrovacesa Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Metrovacesa's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metrovacesa Days Sales Outstanding Competitor Comparison
For the Real Estate - Development subindustry, Metrovacesa's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metrovacesa Days Sales Outstanding vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Metrovacesa's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Metrovacesa's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metrovacesa (XMAD:MVC) has a Days Sales Outstanding of 43.76 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Metrovacesa and its competitors. This is 33% above median its historical median of 32.97. Over the past decade, Metrovacesa's Days Sales Outstanding has ranged from 3.17 to 277.46. According to the industry distribution chart, Metrovacesa ranks #757 out of 1661 companies in the Real Estate industry, placing it in the top 45.6%.
Is Metrovacesa's Days Sales Outstanding too high?
Metrovacesa's current Days Sales Outstanding of 43.76 is 33% above median its 10-year median of 32.97. Over the past 10 years, this metric has ranged from a low of 3.17 to a high of 277.46. The Real Estate industry median Days Sales Outstanding is 34.57. Metrovacesa's value of 43.76 is 26.6% above this industry median. Based on the distribution chart, Metrovacesa ranks #757 out of 1661 companies in the Real Estate industry, which is above the industry midpoint. Overall, Metrovacesa has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Metrovacesa's Days Sales Outstanding compare to competitors?
According to the Real Estate industry distribution chart, Metrovacesa ranks #757 out of 1661 companies for Days Sales Outstanding. This puts Metrovacesa in the upper half of its industry. The industry median Days Sales Outstanding is 34.57. Metrovacesa's value of 43.76 is 26.6% above this benchmark. Historically, Metrovacesa's own Days Sales Outstanding has ranged from 3.17 to 277.46 over the past decade. While the company's 10-year median is 32.97 vs. the industry median of 34.57, Metrovacesa has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Real Estate company?
The median Days Sales Outstanding among Real Estate companies is 34.57, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metrovacesa's current Days Sales Outstanding of 43.76 is 26.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Metrovacesa and its competitors. For the Real Estate industry, the median Days Sales Outstanding is 34.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metrovacesa's current Days Sales Outstanding is 43.76, which is 33% above median its own 10-year median of 32.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrovacesa stock overvalued right now?
Based on GuruFocus' analysis, Metrovacesa (XMAD:MVC) is currently considered Modestly Undervalued. The stock's GF Value™ is €13.62, compared to a current price of €10.92 — trading 19.8% below its estimated fair value. The current Days Sales Outstanding is 43.76, which is 33% above median its 10-year median of 32.97 and 26.6% above the Real Estate industry median of 34.57. Metrovacesa's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Metrovacesa (XMAD:MVC), the current Days Sales Outstanding is 43.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metrovacesa (XMAD:MVC) Overvalued in 2026?
Based on GuruFocus' analysis, Metrovacesa stock appears to be undervalued.
The current stock price of €10.92 is trading 19.8% below its estimated GF Value™ of €13.62.
GuruFocus considers Metrovacesa to be Modestly Undervalued.
Key valuation signals for XMAD:MVC:
Days Sales Outstanding: 43.76 (33% above median its 10-year median of 32.97)
GF Value™: €13.62 vs. price of €10.92 (19.8% below fair value)
Industry Position: 26.6% above the Real Estate median (#757 of 1661)
No single metric tells the full story. See the XMAD:MVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metrovacesa SA is a real estate company. Its operations mainly focus on the development and sale of residential property on land classified as suitable for development. Its operating segments are Residential, Commercial, and Others. The company earns the majority of its revenue through the Residential segment. Geographically, it operates majorly in Spain.
76GF Score
Get the complete analysis for XMAD:MVC
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:MVC has been successfully added to your 
